WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Saptalis launches cyclosporine ophthalmic emulsion 0.05% for dry eye

Saptalis Pharmaceuticals launched generic cyclosporine ophthalmic emulsion 0.05% for the treatment of dry eye disease, according to press release.According to the release, the eye drop, a generic of Restasis (cyclosporine ophthalmic emulsion 0.05%, AbbVie), will be available in 30- and 60-count single-use vials. It is indicated for increasing tear production, providing “a convenient option

Raccontata damorningstar.comhealio.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
healio.comStai leggendo10 g fa

Saptalis launches cyclosporine ophthalmic emulsion 0.05% for dry eye

Saptalis Pharmaceuticals launched generic cyclosporine ophthalmic emulsion 0.05% for the treatment of dry eye disease, according to press release.According to the release, the eye drop, a generic of Restasis…

originale
morningstar.com11 g fa

Saptalis Pharmaceuticals Launches Cyclosporine Ophthalmic Emulsion 0.05% and Expands Product Portfolio

Saptalis launches Cyclosporine 0.05% emulsion (single-use vials) for dry eye, expands portfolio across dermatology, psychiatry, allergy. Specialty pharma consolidates liquid/semi-solid dosages with U.S. manufacturing, signals market shift from generics toward branded innovation.

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 15 giugno 2026·morningstar.com

    Saptalis Pharmaceuticals Launches Cyclosporine Ophthalmic Emulsion 0.05% and Expands Product Portfolio

    Saptalis Pharmaceuticals Launches Cyclosporine Ophthalmic Emulsion 0.05% and Expands Product Portfolio

  2. martedì 16 giugno 2026·healio.com

    Saptalis launches cyclosporine ophthalmic emulsion 0.05% for dry eye

    Saptalis Pharmaceuticals launched generic cyclosporine ophthalmic emulsion 0.05% for the treatment of dry eye disease, according to press release.According to the release, the eye…